Latest & greatest articles for menopause

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on menopause or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on menopause and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for menopause

101. Menopausal hormone therapy: in addition to other risks, an increased risk of ovarian cancer

Menopausal hormone therapy: in addition to other risks, an increased risk of ovarian cancer Prescrire IN ENGLISH - Spotlight ''Menopausal hormone therapy: in addition to other risks, an increased risk of ovarian cancer'', 1 January 2016 {1} {1} {1} | | > > > Menopausal hormone therapy: in addition to other risks, an increased risk of ovarian cancer Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |    (...) |   |   |   |  Spotlight Menopausal hormone therapy: in addition to other risks, an increased risk of ovarian cancer The harm-benefit balance for hormone replacement therapy in menopause is unfavourable due to an increased risk of cardiovascular disease and of breast cancer. It also exposes women to ovarian cancer. At the beginning of 2015, a review of 52 epidemiological studies showed a statistically significant risk of ovarian cancer in women exposed to menopausal

2016 Prescrire

102. Immigrant women's experiences and perceptions of the menopausal transition: a systematic literature review

Immigrant women's experiences and perceptions of the menopausal transition: a systematic literature review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation

2016 PROSPERO

103. Does early environment affect age at menopause: a systematic review and meta- analysis

Does early environment affect age at menopause: a systematic review and meta- analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2016 PROSPERO

104. The effect of vitamin D on uterine leiomyomas in pre-menopausal women: a systematic review and meta-analysis

The effect of vitamin D on uterine leiomyomas in pre-menopausal women: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation

2016 PROSPERO

105. Muscle maintenance after menopause: investigating estrogen and estrogen-progestin hormone replacement therapy use in postmenopausal women and measures of muscle mass

Muscle maintenance after menopause: investigating estrogen and estrogen-progestin hormone replacement therapy use in postmenopausal women and measures of muscle mass Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g

2016 PROSPERO

106. The management of menopause in women with a past history of endometriosis: a systematic review

The management of menopause in women with a past history of endometriosis: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2016 PROSPERO

107. The efficacy of cognitive-behavioral, behavioral and mindfulness-based therapies for menopausal complaints

The efficacy of cognitive-behavioral, behavioral and mindfulness-based therapies for menopausal complaints Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation

2016 PROSPERO

108. Bisphosphonates and denosumab in post-menopausal breast cancer patients on aromatase inhibitors: a systematic review

Bisphosphonates and denosumab in post-menopausal breast cancer patients on aromatase inhibitors: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2016 PROSPERO

109. Effects of Kampo drugs (Kamishoyosan, Tokishakuyakusan, Keishibukuryogan) on menopausal symptoms: protocol for a systematic review and meta-analysis

Effects of Kampo drugs (Kamishoyosan, Tokishakuyakusan, Keishibukuryogan) on menopausal symptoms: protocol for a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2016 PROSPERO

110. Measuring vasomotor menopausal symptoms: a systematic review of valid instruments

Measuring vasomotor menopausal symptoms: a systematic review of valid instruments Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2016 PROSPERO

111. Canadian Consensus on Female Nutrition: Adolescence, Reproduction, Menopause, and Beyond

Canadian Consensus on Female Nutrition: Adolescence, Reproduction, Menopause, and Beyond Canadian Consensus on Female Nutrition: Adolescence, Reproduction, Menopause, and Beyond - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 38, Issue 6, Pages 508–554.e18 Canadian Consensus on Female Nutrition: Adolescence, Reproduction, Menopause, and Beyond Nutrition Working Group x Deborah L. O'Connor , PhD, RD (Principal Author (...) ; FSH, follicle-stimulating hormone; AMH, anti-mullerian hormone Abstract Objectives To provide health care professionals in Canada with the basic knowledge and tools to provide nutrition guidance to women through their lifecycle. Outcomes Optimal nutrition through the female lifecycle was evaluated, with specific focus on adolescence, pre-conception, pregnancy, postpartum, menopause, and beyond. The guideline begins with an overview of guidance for all women, followed by chapters that examine

2016 Society of Obstetricians and Gynaecologists of Canada

112. Limited Evidence Suggests Oral Health Providers Should Observe Caution When Treating Post-Menopausal Women Taking Aromatase Inhibitor (AI) Drugs or Estrogen Modulating Agents

Limited Evidence Suggests Oral Health Providers Should Observe Caution When Treating Post-Menopausal Women Taking Aromatase Inhibitor (AI) Drugs or Estrogen Modulating Agents UTCAT2949, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Limited Evidence Suggests Oral Health Providers Should Observe Caution When Treating Post-Menopausal Women Taking Aromatase Inhibitor (AI) Drugs or Estrogen Modulating Agents Clinical (...) Question Is there an increased risk of alveolar bone loss and dental-related complications in post-menopausal women taking aromatase inhibitor drugs or estrogen/progesterone modulator agents? Clinical Bottom Line Special consideration should be taken regarding the treatment of post-menopausal women taking aromatase inhibitor (AI) drugs. In particular, this includes monitoring periodontal disease, patients undergoing dentoalveolar surgery, and monitoring bone density. Evidence suggests appreciable loss

2015 UTHSCSA Dental School CAT Library

113. Examining the psychometric properties of the brief 'Menopausal Symptoms Distress Affecting Sleep Quality Scale' (Abstract)

Examining the psychometric properties of the brief 'Menopausal Symptoms Distress Affecting Sleep Quality Scale' To examine the psychometric properties of the Menopausal Symptoms Distress Affecting Sleep Quality Scale.Sleep disturbances are an extensive and common problem among menopausal women. However, no unique and specific scale has yet been developed to detect the inductive symptoms distresses that cause poor sleep quality for menopausal women.A cross-sectional design.The Menopausal (...) Symptoms Distress Affecting Sleep Quality Scale was based on in-depth interviews with menopausal women and literature review. Convenience sampling was employed. One hundred and fifty three women participated in this study. Exploratory factor analysis, concurrent validity and contrasting group validity were used to examine the validity of the Menopausal Symptoms Distress Affecting Sleep Quality Scale. Cronbach's α was conducted to test the reliability. The accuracy of the scale was analysed

2015 EvidenceUpdates

114. Periodontal treatment outcomes in post menopausal women receiving hormone replacement therapy Full Text available with Trip Pro

Periodontal treatment outcomes in post menopausal women receiving hormone replacement therapy To evaluate the effect of hormone replacement therapy(HRT) on periodontal treatment outcomes in a group of postmenopausal women with periodontitis.23 post-menopausal chronic periodontitis patients were included in this study. The test group(n=11) consisted of women who started HRT with this study and received conjugated estrogen and medroxyprogesteron. The control group(n=12) was women not taking any

2015 Journal of Istanbul University Faculty of Dentistry Controlled trial quality: uncertain

115. Women's experience of menopause: a systematic review of qualitative evidence. (Abstract)

Women's experience of menopause: a systematic review of qualitative evidence. Evidence shows than an estimated one billion women have experienced menopause worldwide. The experience of menopause is influenced by beliefs and values prevalent in the sociocultural setting, the background of the women, and the ways in which the women approach changes in this phase of life. Independently of the circumstances involved, women experiencing menopause need to have their care needs and corresponding (...) support identified based on their personal and contextual perspectives. Although it is essential to provide appropriate support to women experiencing menopause, no systematic reviews have so far been conducted that focus on menopause experienced by women worldwide.The objective of this review is to identify the best available evidence related to how women experience menopause worldwide.This review considered studies that included menopausal women aged between 40 and 65 years, who have lived

2015 JBI database of systematic reviews and implementation reports

116. No sex please, we’re menopausal!

No sex please, we’re menopausal! No sex please, we're menopausal! - Evidently Cochrane Search and hit Go By March 13, 2015 // In today’s guest blog, Elaine Miller, a physiotherapist who also does a stand-up comedy show about pelvic floors, tackles sex and the menopause. I have a faded post-it note on my office wall that says “what most people need is a really good listening to”. It’s sound advice for life, but, particularly useful whenever a patient brings up a sexual function issue in clinic (...) . Menopausal women often experience changes in how they think about their bodies and sexuality. Many have sad feelings about the loss of fertility and the body of their youth. Of course, some women relish not fearing unwanted pregnancy and finally feeling comfortable in their own skin. Elaine Miller, tackling the taboo with humour and reliable information. Sexuality is not just about having sex, and sex is about more than penetration. A lack of intimacy, in whatever form, negatively impacts our wellbeing

2015 Evidently Cochrane

117. Hormone Therapy for the Menopause after Endometriosis Surgery – Friend or Foe?

Hormone Therapy for the Menopause after Endometriosis Surgery – Friend or Foe? Hormone Therapy for the Menopause after Endometriosis Surgery - Friend or Foe? - Evidently Cochrane Search and hit Go By March 12, 2015 // In today’s guest blog, Dr Martin Hirsch explains about endometriosis and treatment choices for women who have the menopause induced because of it. It’s Menopause Week here at Evidently Cochrane and as a team including individual bloggers, Cochrane UK, Healthtalk and Menopause UK (...) with their NHS Change Day campaign to ‘Change the Change’, we are summarising the evidence surrounding the menopause to ensure women get the correct facts from reliable evidence. This blog aims to help women who have had the menopause induced through surgery for endometriosis make more informed health decisions at a time of significant change for their mind and body. Endometriosis – what is it and how do I know if I have it? Most women have heard of the menopause. They fear it, but for a select few women

2015 Evidently Cochrane

118. Everything I needed to know about the menopause… No One Told Me

Everything I needed to know about the menopause… No One Told Me Everything I needed to know about the menopause... No One Told Me - Evidently Cochrane Search and hit Go By March 11, 2015 // Today’s guest blog comes from Oxford academic June Girvin, who shares her experiences of the menopause, the taboo and the information gap. Today is NHS Change Day and June, along with the rest of our guest bloggers in this special series on the menopause, is backing Menopause UK’s grassroots campaign (...) for Change Day to #changethechange. You can read more about that here. It’s Menopause Week on Evidently Cochrane. I wasn’t sure whether that required an exclamation mark, but decided, all things considered, that it didn’t. My contribution to this week of menopause related blogs is a personal one – or a phenomenological one as this is a blog for ‘Evidently Cochrane’ – and I think my lived experience of the ‘last taboo’ or the ‘Big M’ (thankfully one rarely hears it called ‘THE CHANGE’ anymore with all its

2015 Evidently Cochrane

119. Let’s talk about the menopause

Let’s talk about the menopause Let's talk about the menopause - Evidently Cochrane Search and hit Go By March 6, 2015 // In the first of our series of guest blogs about the menopause and health, Jenny Hislop , a Senior Qualitative Researcher in the (HERG) at the University of Oxford, talks about her research on the menopause and collecting women’s stories for the website. The website healthtalk.org “brings the menopause into the open.” A few years ago I had the privilege of interviewing 46 (...) women throughout the UK about their experiences of the menopause for the award-winning website What impressed me most was their willingness to talk openly about the menopause and its impact on their everyday lives. And it takes courage to do this. We live in a society where we tend to build a wall of silence around personal matters like the menopause – it’s something we keep hidden and as a result no one really knows what to expect. And I think this is one of the key strengths of the menopause site

2015 Evidently Cochrane

120. Making sense of the menopause: experience, evidence and you

Making sense of the menopause: experience, evidence and you Making sense of the menopause: experience, evidence and you - Evidently Cochrane Search and hit Go By March 6, 2015 // Let’s talk about the menopause. We really need to! We’ve designated next week Menopause Week on Evidently Cochrane and this afternoon we start a series of six guest blogs on the menopause, from women brave enough to share their experiences and doctors and researchers with the latest evidence on treatments. We’re also (...) supporting in their actions for NHS Change Day on March 11th which they hope will #changethechange. It’s unthinkable that we wouldn’t tell girls about menstruation, yet this other stage in women’s lives is not freely discussed and women are arriving at it unprepared. This isn’t so in all cultures and in those where aging conveys status the menopause is often treated rather differently. Louise Foxcroft has noted, in her excellent book on the modern menopause, that modern Jewish Orthodox practice has begun

2015 Evidently Cochrane